Skip to main content
Caplight Logo









Optic

Optic

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://bioptic.io/

Last Round

Seed

Jul 20, 2022

Total Funding Raised

$11M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Optic is a biotechnology company that provides an AI-powered platform for drug discovery, asset identification, and strategic intelligence for the biopharma industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Business Intelligence

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Foundation

Keywords

drug discoverymolecular discoveryagentic AIAI drug discoverybiotech AIin silico drug discoverycompetitive intelligencesmall-molecule discoveryAI agentsbiopharma R&DAI-driven researchdrug asset identificationbiotech ventureAI-first biotechdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Optic Comparables

Compare Optic with similar companies based on industry and business-model similarity.

Optic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Convexia
79%
Perceptic
76%
Xaira Therapeutics
75%

Optic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 20, 2022

Key People

Founding team and executive leadership

Vlad Vinogradov

Co-founder CTO

Founding Team

Andrey Doronichev

Founder, CEO

Founding Team

Optic Investors

Notable investors and investment history

Optic investors
InvestorRounds
Greylock PartnersSeed
Neon DAOSeed
Kleiner PerkinsSeed
Pantera CapitalSeed
Lattice CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 61% MoM, reaching 9.4K.

  • Feb 23, 2026

    Published paper on AI-driven drug asset scouting with Luba Greenwood.

Optic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Optic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Optic's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range283
Year Founded2022
Last FundingJul 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?